Goldman Sachs’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,400
Closed -$259K 6298
2025
Q2
$259K Buy
+11,400
New +$270K ﹤0.01% 5526
2017
Q3
Sell
-229,000
Closed -$11.3M 6629
2017
Q2
$11.3M Buy
229,000
+129,000
+129% +$5.71M ﹤0.01% 2413
2017
Q1
$4.36M Buy
+100,000
New +$4.06M ﹤0.01% 3053

Other funds holding ACHC

Goldman Sachs's ACHC Position: Q1 2026 in Review

Goldman Sachs reduced its Acadia Healthcare (ACHC) stake by 53% in Q1 2026, selling an estimated $45M and leaving 2,240,428 shares worth $52.4M. The position accounts for 0.01% of the portfolio, ranked #1540.

Goldman Sachs first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $216M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Goldman Sachs held 2,240,428 shares of Acadia Healthcare worth $52.4M as of Q1 2026.
  • Goldman Sachs sold 2,488,185 Acadia Healthcare shares in Q1 2026, an estimated $45M.
  • Acadia Healthcare made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1540 holding.
  • Goldman Sachs first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Acadia Healthcare position peaked at $216M in Q2 2017.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.